raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:244275

De novo thrombotic microangiopathy after kidney transplantation

Type
Particular clinical situation in a disease or syndrome
Group
Disorder
Age of onset
All ages
Status
active

A rare renal disease characterized by thrombotic microangiopathy developing <i>de novo</i> in kidney transplant recipients with no evidence of occurrence of the disease prior to transplantation. Precipitating factors include antibody-mediated rejection, immunosuppressive medication, viral infections, and genetic abnormalities in the complement cascade, among others. The condition most commonly occurs within the first 3-6 months post-transplantation. Clinical presentation is highly variable and ranges from a limited form confined to the kidney with relatively good prognosis to a systemic variant consisting of the classic triad of thrombocytopenia, microangiopathic hemolytic anemia, and acute kidney injury.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDe novo thrombotic microangiopathy after kidney transplantation
frMicroangiopathie thrombotique de novo après transplantation rénale
deDe-novo thrombotische Mikroangiopathie nach Nierentransplantation
esMicroangiopatía trombótica de novo post-trasplante renal
itMicroangiopatia trombotica de novo successiva a trapianto renale
nlDe novo trombotische microangiopathie na niertransplantatie
ptMicroangiopatia trombótica de novo após transplante renal
plMikroangiopatia zakrzepowa powstająca de novo po transplantacji nerki
csDe novo vznik trombotické mikroangiopatie po transplantaci ledviny
ukТромботична мікроангіопатія de novo після трансплантації нирки
zh肾移植后新发血栓性微血管病
trBöbrek nakli sonrası de novo trombotik mikroanjiyopati

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10M31.1NTBTattributednot yet validated
ICD-11NE8YNTBTattributedvalidated
UMLSC5680696Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CFHBiomarker tested inAssessedHGNC:4883ENSG000000009711343701q31.3complement factor H
CFIBiomarker tested inAssessedHGNC:5394ENSG000002054032170304q25complement factor I
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card